Neurocrine Biosciences Financial Statements 2009-2025 | NBIX

Revenue

$2,355.3

$1,887.1

$1,488.7

$1,133.5

$1,045.9

$788.1

$451.2

$161.626

$15

$19.769

Cost Of Goods Sold

$34

$39.7

$23.2

$14.3

$10.1

$7.4

$4.9

$1.254

Gross Profit

$2,321.3

$1,847.4

$1,465.5

$1,119.2

$1,035.8

$780.7

$446.3

$160.372

$15

$19.769

Research And Development Expenses

$731.1

$565

$463.8

$328.1

$275

$200

$155.8

$91.827

$94.291

$81.491

SG&A Expenses

$1,007.2

$887.6

$752.7

$583.3

$433.3

$354.1

$248.9

$169.906

$68.081

$32.48

Other Operating Income Or Expenses

Operating Expenses

$1,750.8

$1,596.5

$1,216.5

$1,016.7

$872.8

$708.4

$409.5

$291.733

Operating Income

$570.5

$250.9

$249

$102.5

$163

$72.3

$36.8

$-131.361

$-147.372

$-94.202

Total Non-Operating Income/Expense

$-84.5

$81.2

$-35.1

$-1.1

$-56.3

$-25.8

$-15

$-11.181

$6.282

$5.273

Pre-Tax Income

$486

$332.1

$213.9

$101.4

$106.7

$46.5

$21.8

$-142.542

$-141.09

$-88.929

Income Taxes

$144.7

$82.4

$59.4

$11.8

$-300.6

$9.5

$0.7

Income After Taxes

$341.3

$249.7

$154.5

$89.6

$407.3

$37

$21.1

$-142.542

$-141.09

$-88.929

Other Income

Income From Continuous Operations

$341.3

$249.7

$154.5

$89.6

$407.3

$37

$21.1

$-142.542

$-141.09

$-88.929

Income From Discontinued Operations

Net Income

$341.3

$249.7

$154.5

$89.6

$407.3

$37

$21.1

$-142.542

$-141.09

$-88.929

EBITDA

$571.4

$253.9

$268.3

$138.1

$193

$100

$59.7

$-115.42

$-142.399

$-87.161

EBIT

$570.5

$250.9

$249

$102.5

$163

$72.3

$36.8

$-131.361

$-147.372

$-94.202

Basic Shares Outstanding

100

Shares Outstanding

104

101

Basic EPS

$3.40

$2.56

$1.61

$0.95

$4.38

$0.40

$0.23

$-1.62

$-1.63

$-1.05

EPS - Earnings Per Share

$3.29

$2.47

$1.56

$0.92

$4.16

$0.39

$0.22

$-1.62

$-1.63

$-1.05